Investment State-of-Play in Big Pharma: Bayer’s Eugene Borukhovich Weighs In
Bayer’s G4A team has just launched their 2019 program. Are you a startup interested in applying? A health tech innovator wondering what a big pharma co…
Bayer’s G4A team has just launched their 2019 program. Are you a startup interested in applying? A health tech innovator wondering what a big pharma co…
An article by Dominic Tyer, Creative Director at pharmaphorum Connect Eleven years is a long time to be writing about ‘digital pharma’, and I do indee…
The case for increasing representation in digital health investing When it comes to digital health, investors get a bird’s eye view and play a major r…
An interview by Richard Staines, journalist at pharmaphorum, with Jeanne Barnett, founder of the website CysticFibrosis.com and blockchain advocate, ab…
Transforming people is not for faint-hearted managers One of the biggest challenges in transforming a company is to keep a workforce up to date with t…
At CES 2019, the digital therapeutic company's CEO and cofounder described work on an independent prescription, procurement and support platform specif…
“Health insurers will rapidly move from passive payers to active players” – this is the key finding of a Masterclass on disruptive digital business mod…
Yesterday I joined 600 digital health innovators and experts at the first day of the Frontiers Health conference in Berlin’s historic Funkhaus radio st…
What does digital disruption mean for healthcare? Who are the main players driving innovation? What does this mean for patients? And...how is it being …
Regardless of where in the world you’re working to transform the healthcare industry, you need to understand the ‘consumer health movement’ and how it’…